NCT02639520View on ClinicalTrials.gov

Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs

PHASE3CompletedINTERVENTIONAL
Enrollment

659

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

June 29, 2017

Conditions
Urinary Tract Infection
Interventions
DRUG

Canephron® N

2 tablets 3 times a day for 7 days

DRUG

Fosfomycin trometamol

1 sachet of 8 g of granules; one single dose on Day 1

DRUG

Canephron® N-placebo

2 tablets 3 times a day for 7 days

DRUG

Fosfomycin trometamol-placebo

1 sachet of 8 g of granules; one single dose on Day 1

Trial Locations (1)

35392

Justus-Liebig-Universität, Giessen

Sponsors

Lead Sponsor

Bionorica SE
All Listed Sponsors
lead

Bionorica SE

INDUSTRY